MR cisternography for trigeminal neuralgia: comparison between gradient-echo and spin echo 3D sequences
Dentomaxillofacial Radiology · 2025
DOI: 10.1093/dmfr/twaf015 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Dentomaxillofacial Radiology, 2025. Verfasst von Natnicha Wamasing und 5 weiteren Autor:innen. Beteiligte Einrichtung: Dental Radiology and Radiation Oncology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo 113-8549, 1-5-45 Yushima, …. Hauptthemen laut MEDLINE: Trigeminal Neuralgia, Magnetic Resonance Imaging, Imaging, Three-Dimensional. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben. Gefördert von: JSPS KAKENHI.
Abstract (Originalsprache)
Objective
To quantitatively and qualitatively compare directly 2 types of cisternography images for diagnosing trigeminal neuralgia (TN) using 3-T MRI.
Methods
This prospective study recruited 64 patients with a clinical diagnosis or suspicion of TN. Patients were examined through the three-dimensional Constructive Interference in Steady State (CISS) and Sampling Perfection with Application-optimized Contrasts using different flip angle Evolutions (SPACE) sequences. Three radiologists quantitatively measured the signal intensity of the trigeminal nerve (cranial nerve V, CN5) (SICN5), cerebrospinal fluid (CSF) (SICSF), and contrast between CN5 and CSF (Cont.). Additionally, 2 radiologists qualitatively evaluated the basilar artery (BA), CN5, CSF, image artefacts, and overall image quality. Statistical analyses included paired-sample t-tests, non-parametric McNemar tests, and the Friedman test (significance set at P < .05).
Results
Mean SICN5 (P < .001), SICSF (P = .679), and Cont. (P < .001) were as follows: 203.08 ± 26.68, 936.03 ± 91, and 3.68 ± 0.74 in CISS; 46.80 ± 16.88, 940.61 ± 71.39, and 23.19 ± 14.52 in SPACE. Low-to-moderate CN5 and BA visibility was observed in all cases in CISS, while it was noted in one case for CN5 and in none for BA in SPACE (P < .001). Homogenous CSF and minor artefacts were observed in 14 cases in CISS, while it was seen in 52 cases for CN5 and 59 for BA in SPACE (P < .001). The overall image quality was scored as 4 in 57 cases in SPACE, while no cases received this score in CISS (P < .001).
Conclusions
Sampling Perfection with Application-optimized Contrasts using different flip angle Evolutions provided better images than CISS for evaluating CN5 and prepontine cistern vascularity, indicating a valuable sequence for TN diagnosis. Advances in knowledge This study indicates that SPACE should be selected for TN diagnosis instead of CISS sequence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Dental Radiology and Radiation Oncology, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo 113-8549, 1-5-45 Yushima, Bunkyo-ku, Japan.
- Faculty of Dentistry, Siam University, Bangkok, 38 Petchkasem Road, Bangwa, Phasicharoen, Thailand.
- Radiology Center, Division of Integrated Facilities, Institute of Science Tokyo Hospital, Tokyo, Yushima 1-5-45, Bunkyo-ku, Japan.
ORCID-Profile: Hiroshi Watanabe
Förderung
- JSPS KAKENHI
Zitieren
APA
Wamasing, N., Watanabe, H., Kuribayashi, A., Imaizumi, A., Sakamoto, J., & Tomisato, H. (2025). MR cisternography for trigeminal neuralgia: comparison between gradient-echo and spin echo 3D sequences. Dentomaxillofacial Radiology. https://doi.org/10.1093/dmfr/twaf015
Vancouver
Wamasing N, Watanabe H, Kuribayashi A, Imaizumi A, Sakamoto J, Tomisato H. MR cisternography for trigeminal neuralgia: comparison between gradient-echo and spin echo 3D sequences. Dentomaxillofacial Radiology. 2025. doi:10.1093/dmfr/twaf015
BibTeX
@article{Wamasing2025,
author = {Wamasing, Natnicha and Watanabe, Hiroshi and Kuribayashi, Ami and Imaizumi, Akiko and Sakamoto, Junichiro and Tomisato, Hiroshi},
title = {MR cisternography for trigeminal neuralgia: comparison between gradient-echo and spin echo 3D sequences},
journal = {Dentomaxillofacial Radiology},
year = {2025},
doi = {10.1093/dmfr/twaf015}
}
EUVIMED